查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935640

氣喘監測設備市場按產品類型、技術、通路、電源、應用、年齡層和最終用戶分類，全球預測，2026-2032年

Asthma Monitoring Devices Market by Product Type, Technology, Distribution Channel, Power Source, Application, Age Group, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，氣喘監測設備市場價值將達到 20.5 億美元，到 2026 年將成長至 22.2 億美元，到 2032 年將達到 37.3 億美元，複合年成長率為 8.94%。

關鍵市場統計數據
基準年 2025 20.5億美元
預計年份：2026年 22.2億美元
預測年份 2032 37.3億美元
複合年成長率 (%) 8.94%

本文權威概述了數位感測技術、日益嚴格的監管以及不斷變化的醫療服務模式如何重塑氣喘監測設備的臨床和消費者使用方式。

氣喘監測設備如今已成為臨床需求、數位創新和消費者健康參與三者交會的焦點。感測技術、連接通訊協定和以使用者為中心的設計的快速發展，重新定義了臨床醫生和患者監測呼吸功能和管理慢性疾病的方式。在藥物依從性和早期發現直接影響臨床結果的環境下，智慧吸入器和穿戴式監測器等設備不再是輔助設備，而是成為診療路徑中不可或缺的一部分。

感測器小型化、智慧型手機整合、遠端醫療優先發展以及數據管治將如何從根本上重塑氣喘監測價值鏈

由於技術、醫療服務模式和患者期望三方因素的共同作用，氣喘監測設備領域正經歷變革性的轉變。微型感測器和低功耗無線通訊協定的進步催生了新一代設備，這些設備能夠在最大限度減輕用戶負擔的同時，持續收集生理數據。同時，智慧型手機整合和雲端分析技術的進步，使得趨勢檢測、自動警報以及與電子健康記錄的整合成為可能，從而提升了設備生成數據的實用價值。

評估2025年關稅調整如何重塑氣喘監測設備生態系統的供應鏈、採購計算與供應商策略

2025年實施的累積關稅措施對醫療設備供應鏈和籌資策略產生了即時且連鎖的影響。依賴跨境採購電子元件、機殼和感測器的製造商面臨投入成本增加和前置作業時間延長的雙重挑戰。為此，一些公司尋求供應商多元化並加快供應商資質認證流程，而另一些公司則重新評估了國內生產與海外成本優勢之間的權衡。

深度細分分析揭示了產品類型、連接偏好、通路、電源設計、臨床應用、年齡層和最終用戶採用路徑如何決定採用路徑

對設備類別和部署環境的詳細分析揭示了產品、技術、分銷、電源、應用、人口統計和最終用戶等各個細分領域的清晰採用趨勢。產品類型涵蓋電子氣喘監測儀、尖峰流量計、脈動式血氧監測儀系統、智慧吸入器、肺計量計以及穿戴式監測設備。在穿戴式裝置領域，心率、血氧飽和度和呼吸頻率感測器可滿足不同的臨床應用情境和不同的檢驗要求。這些設備擴大採用互聯架構或智慧型手機整合模型。互聯類別又可細分為藍牙、蜂窩網路和 Wi-Fi 通訊技術，每種技術都會影響互通性、資料延遲和電力消耗。

區域比較分析揭示了法規結構、支付模式、製造能力和醫療保健優先事項如何影響世界各地醫療器材的普及應用。

區域趨勢將對美洲、歐洲、中東和非洲以及亞太地區的監管路徑、報銷模式和普及速度產生重大影響。在美洲，強大的醫院網路和支付方對基於價值的醫療服務日益成長的興趣正在加速對能夠展現臨床效用並支持遠端系統管理的設備的需求，而私營部門的創新生態系統則在推動消費級設備的開發。從早期採用者到更廣泛的機構採用的轉變通常取決於證據的產生以及與醫療服務提供者IT系統的整合。

競爭格局分析凸顯了臨床可靠性、數位化優先的參與企業、夥伴關係和服務導向模式如何重新定義差異化和規模化擴大策略。

氣喘監測設備市場的競爭格局呈現出多元化的特點，既有成熟的醫療設備製造商，也有敏捷的數位醫療Start-Ups公司，還有整合硬體、軟體和服務的垂直整合型企業。現有企業憑藉其臨床信譽、監管經驗和成熟的分銷網路，與醫院和診斷中心保持良好的合作關係。同時，新參與企業則專注於使用者體驗、快速的產品改進和雲端分析，以吸引消費者和門診病人的注意。

為醫療設備製造商和醫療系統領導者建構臨床可靠性、互通性、彈性供應鏈和靈活的商業模式提供切實可行、優先考慮和具有戰略意義的步驟。

產業領導者應採取一系列切實可行的措施，將技術潛力轉化為持續的臨床和商業性成果。首先，應優先在具有代表性的患者群體中進行嚴格的臨床檢驗，以建立與臨床醫生和支付方的信任。應投資進行前瞻性研究和真實世界證據收集，重點關注藥物依從性、病情惡化預防和護理協調指標。其次，應設計互通性的設備平台，透過採用開放標準和提供完善的API文檔，促進與電子健康記錄和遠端醫療服務的整合。

我們採用透明、多維度的研究途徑，整合相關人員訪談、臨床檢驗審查、技術評估和供應鏈情境分析，以確保獲得嚴謹的洞見。

本研究整合了初級研究和二級研究，並採用系統性的證據和品質保證方法。初級研究資料包括對臨床負責人、採購專業人員、器械工程師和支付方代表的訪談，並輔以對器械規格、監管申報文件和產品文獻的技術評估。二級資訊來源包括同行評審的臨床研究、監管指導文件和公開的產品訊息，並對這些數據進行三角驗證，以檢驗器械功能和典型部署場景。

綜合分析表明，檢驗的感測技術、互通性、供應鏈韌性和協調一致的商業模式是永續應用和臨床影響的基礎。

總之，氣喘監測設備正處於關鍵的轉折點。技術能力的提升、臨床對遠端系統管理的需求以及不斷變化的採購趨勢，共同為製造商、醫療服務提供者和支付方創造了新的機會和挑戰。具備檢驗的感測技術、無縫連接和顯著臨床效用的設備將成為醫療機構的首選。同時，面向消費者的解決方案必須在易用性和臨床數據的可靠性之間取得平衡。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的氣喘監測設備市場

  • 電子氣喘監測儀
  • 峰值流量計
  • 脈動式血氧監測儀系統
  • 智慧吸入器
  • 肺計量計
  • 穿戴式監測設備
    • 心率感測器
    • 氧飽和度感測器
    • 呼吸頻率感測器

第9章 依技術分類的氣喘監測設備市場

  • 連接類型
    • Bluetooth
    • 細胞
    • Wi-Fi
  • 內建智慧型手機

第10章 按分銷通路分類的氣喘監測設備市場

  • 直銷
  • 醫院藥房
  • 網路藥房
  • 零售藥房
    • 店鋪
    • 網路市集

第11章氣喘監測設備市場（依來源分類）

  • 電池供電
  • 插座連接類型
  • 可充電的

第12章 按應用分類的氣喘監測設備市場

  • 氣喘診斷支持
  • 每日症狀追蹤
  • 藥物依從性監測
  • 肺功能監測
  • 遠端患者監護（RPM）

第13章 按年齡層別分類的氣喘監測設備市場

  • 成人
  • 老年人
  • 兒童

第14章 依最終用戶分類的氣喘監測設備市場

  • 門診手術中心（ASC）
  • 診斷檢查室
  • 居家醫療環境
  • 醫院和診所
  • 研究和學術機構

第15章氣喘監測設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 按組別分類的氣喘監測設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國氣喘監測設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

18. 美國氣喘監測設備市場

第19章 中國氣喘監測設備市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Adherium Limited
  • Amiko Digital Health Limited
  • AptarGroup, Inc.
  • AstraZeneca plc
  • FindAir
  • Health Care Originals, Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • MGC Diagnostics Corporation
  • Microlife Corporation
  • Nihon Kohden Corporation
  • Novartis AG
  • Omron Healthcare, Inc.
  • Sensirion AG
  • Strados Labs, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vitalograph Ltd.
Product Code: MRR-9A6A6F29743D

The Asthma Monitoring Devices Market was valued at USD 2.05 billion in 2025 and is projected to grow to USD 2.22 billion in 2026, with a CAGR of 8.94%, reaching USD 3.73 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.05 billion
Estimated Year [2026] USD 2.22 billion
Forecast Year [2032] USD 3.73 billion
CAGR (%) 8.94%

An authoritative overview of how digital sensing, regulatory rigor, and care delivery shifts are reshaping clinical and consumer approaches to asthma monitoring devices

Asthma monitoring devices now sit at the nexus of clinical need, digital innovation, and consumer health engagement. Rapid advances in sensing technologies, connectivity protocols, and user-centered design have redefined how clinicians and patients monitor respiratory function and manage chronic conditions. In a landscape where adherence and early detection directly influence clinical outcomes, devices such as smart inhalers and wearable monitors are no longer adjuncts but integral components of care pathways.

As healthcare systems emphasize value-based care and remote management, stakeholders increasingly demand evidence that devices deliver actionable, interoperable, and secure data streams. At the same time, regulatory scrutiny around data privacy, device validation, and clinical utility has intensified, prompting manufacturers to invest in rigorous clinical validation and robust cybersecurity measures. Collectively, these forces are reshaping procurement preferences, partnership models, and go-to-market strategies.

Consequently, organizations must navigate a dense and evolving environment that blends medical device engineering, cloud connectivity, and behavioral science. This introduction sets the stage for a deeper analysis of disruptive shifts, regulatory and trade headwinds, segmentation dynamics, and regional considerations that together determine how asthma monitoring technologies are adopted, scaled, and integrated across care settings.

How sensor miniaturization, smartphone integration, remote care priorities, and data governance are driving a fundamental reconfiguration of asthma monitoring value chains

The landscape for asthma monitoring devices is undergoing transformative shifts driven by converging forces in technology, healthcare delivery, and patient expectations. Advances in miniaturized sensors and low-power wireless protocols have enabled a new generation of devices that capture continuous physiologic data while minimizing user burden. In parallel, improvements in smartphone integration and cloud-based analytics have increased the practical value of device-generated data by enabling trend detection, automated alerts, and integration with electronic health records.

Meanwhile, healthcare delivery reforms favoring remote patient monitoring and chronic disease management have opened new channels for device deployment beyond traditional clinical settings. Payers and providers are also incentivizing outcomes-focused solutions, which increases demand for devices that can demonstrate real-world clinical impact and adherence improvements. In response, manufacturers are shifting from selling hardware to delivering end-to-end solutions that combine devices, software, and services.

Crucially, interoperability and data governance have moved from optional considerations to core requirements. Regulators and healthcare customers expect devices to meet stringent privacy standards and to provide transparent evidence for their algorithms. As a result, partnerships between device makers, digital health platforms, and clinical organizations are becoming the norm, and companies that can marry technological sophistication with clinical validation and operational scalability will lead the next wave of adoption.

Assessing how 2025 tariff changes reconfigured supply chains, procurement calculus, and supplier strategies across the asthma monitoring device ecosystem

The introduction of cumulative tariff measures in 2025 created immediate and cascading effects across supply chains and procurement strategies for medical devices. Manufacturers that rely on cross-border sourcing of electronic components, housings, and sensors experienced increased input costs and longer lead times. In response, some firms diversified their supplier base and accelerated supplier qualification processes, while others re-evaluated the tradeoffs between onshore production and offshore cost advantages.

These trade policy shifts also influenced pricing strategies and contract negotiations with distributors and healthcare purchasers. Procurement professionals faced new considerations around total landed cost, warranty terms, and inventory buffering to insure against future tariff volatility. Consequently, device makers with vertically integrated capabilities or localized assembly footprints had a relative advantage in maintaining predictable delivery schedules and negotiating stable pricing with institutional buyers.

Moreover, the broader commercial environment prompted greater emphasis on supply chain transparency and scenario planning. Companies invested in dual-sourcing strategies, enhanced inventory visibility tools, and supplier risk assessments to mitigate the impact of future tariff movements. Taken together, these developments reinforced the importance of resilient operations and adaptive commercial models in ensuring continued access to critical monitoring technologies for patients and clinicians.

Deep segmentation insights revealing how product types, connectivity choices, distribution routes, power design, clinical applications, age cohorts, and end users determine adoption pathways

A granular view of device categories and deployment contexts reveals distinct adoption dynamics across product, technology, distribution, power, application, age group, and end-user segments. Product types range from electronic asthma monitors, peak flow meters, pulse oximeters, smart inhalers, and spirometers to wearable monitoring devices; within wearables, heart rate sensors, oxygen saturation sensors, and respiratory rate sensors support diverse clinical use cases and differing validation requirements. These devices are increasingly built on either connected architectures or smartphone-integrated models; the connected category further subdivides into Bluetooth, cellular, and Wi-Fi modalities, each affecting interoperability, data latency, and power consumption.

Distribution pathways include direct sales to institutional buyers, hospital pharmacies, online pharmacies, and retail pharmacies, with retail further divided into brick-and-mortar and online marketplace channels that influence customer acquisition and after-sales support. Power options-battery-operated, plug-in electric, and rechargeable-shape usability and lifecycle costs across home and clinical settings. Application domains encompass support for asthma diagnosis, daily symptom tracking, medication adherence monitoring, pulmonary function assessment, and remote patient monitoring, and these applications often determine required regulatory evidence and integration needs.

Age group segmentation differentiates adults, geriatric patients, and pediatrics, which in turn affects form factor, usability testing, and clinical endpoints. Finally, end users such as ambulatory surgical centers, diagnostic laboratories, homecare settings, hospitals and clinics, and research and academic institutes have unique procurement cycles, technical requirements, and support expectations. Understanding how these overlapping segments interact enables more precise product positioning and commercialization strategies.

Comparative regional analysis highlighting how regulatory frameworks, payer models, manufacturing capacity, and healthcare priorities shape device adoption across global regions

Regional dynamics exert a powerful influence on regulatory pathways, reimbursement models, and adoption tempo across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong hospital networks and growing payer interest in value-based care accelerate demand for devices that can demonstrate clinical utility and support remote management, while private-sector innovation ecosystems foster consumer-facing device development. Transitioning from early adopters to broader institutional uptake often depends on evidence generation and integration with provider IT systems.

In Europe, Middle East & Africa, regulatory frameworks emphasize device safety and data protection, and regional fragmentation in reimbursement creates heterogeneous uptake patterns that favor devices adaptable to multiple payer environments. Additionally, several markets in the region prioritize public procurement, which places a premium on cost transparency and long-term service agreements. Meanwhile, Asia-Pacific presents a mix of advanced digital health initiatives and high-volume manufacturing capacity; policy emphasis on domestic capability building and public health programs can create large-scale deployment opportunities for cost-effective devices that meet local regulatory standards.

Across regions, interoperability standards, clinician workflows, and consumer preferences vary significantly, which means global product strategies must be tailored to local regulatory requirements, distribution ecosystems, and procurement behaviors. Successful regional entry plans emphasize partnerships, localized clinical validation, and flexible commercial models that accommodate unique payer and customer landscapes.

Competitive landscape intelligence showing how clinical credibility, digital-first entrants, partnerships, and service-oriented models are redefining differentiation and scale-up strategies

Competitive dynamics in the asthma monitoring devices landscape are characterized by a mix of established medical device firms, nimble digital health startups, and vertically integrated companies that combine hardware, software, and services. Incumbent manufacturers often leverage clinical credibility, regulatory experience, and established distribution networks to maintain relationships with hospitals and diagnostic centers. Conversely, newer entrants frequently focus on user experience, rapid iteration, and cloud-enabled analytics to capture attention in consumer and outpatient segments.

Strategic partnerships and M&A activity have emerged as common pathways to scale, enabling device makers to pair clinical-grade hardware with advanced data platforms, telehealth providers, or pharmacy channels. Companies that prioritize clinical validation, interoperability, and post-market support gain traction with institutional buyers who demand predictable performance and integration with electronic health systems. At the same time, firms that invest in robust cybersecurity measures and transparent algorithmic performance build trust with both clinicians and regulators.

Service models that bundle devices with subscription-based analytics, adherence programs, and clinician dashboards are becoming more prevalent, as they align vendor incentives with clinical outcomes. Ultimately, competitive advantage flows to organizations that can demonstrate not only product reliability and clinical value but also operational scalability and a clear path to integration within care delivery workflows.

Practical and prioritized strategic steps for device makers and health system leaders to build clinical credibility, interoperability, resilient supply chains, and flexible commercial models

Industry leaders should pursue a pragmatic set of actions to convert technological promise into durable clinical and commercial outcomes. First, prioritize rigorous clinical validation across representative patient cohorts to build trust with clinicians and payers; invest in prospective studies and real-world evidence collection that focus on adherence, exacerbation reduction, and care coordination metrics. Second, design devices and platforms for interoperability by adopting open standards and providing well-documented APIs to facilitate integration with electronic health records and telehealth services.

Third, strengthen supply chain resilience by diversifying component suppliers, qualifying alternative manufacturing sites, and implementing transparent inventory monitoring to reduce exposure to trade policy shocks. Fourth, offer flexible commercial models that include bundled services, outcome-linked contracts, and tiered licensing to align value capture with payer and provider incentives. Fifth, embed privacy and cybersecurity by design, ensuring encryption, secure device provisioning, and clear data governance to meet regulatory expectations and stakeholder requirements.

Finally, cultivate cross-sector partnerships with pharmacies, payers, and clinical networks to expand distribution channels and support adoption. By sequentially addressing clinical credibility, technical interoperability, operational resilience, and commercial flexibility, leaders can accelerate sustainable adoption while reducing friction for institutional and consumer customers alike.

A transparent, multi-source research approach combining stakeholder interviews, clinical validation review, technical assessments, and supply chain scenario analysis to ensure rigorous findings

This study synthesizes primary and secondary research with a structured approach to evidence and quality assurance. Primary inputs include interviews with clinical leaders, procurement professionals, device engineers, and payer representatives, supplemented by technical evaluations of device specifications, regulatory filings, and product literature. Secondary sources encompass peer-reviewed clinical studies, regulatory guidance documents, and publicly available product information, which were triangulated to validate device capabilities and typical deployment scenarios.

Analytical methods included qualitative thematic analysis of stakeholder interviews, comparative assessment of device feature sets and connectivity profiles, and scenario-based supply chain risk mapping to understand operational sensitivities. Special attention was given to clinical validation requirements and interoperability standards to reflect real-world integration challenges. Throughout, findings were cross-checked by domain experts to ensure technical accuracy and to contextualize commercial implications.

Limitations and caveats are acknowledged, including variability in clinical adoption timelines across regions and the evolving regulatory landscape. To mitigate bias, multiple sources were used to corroborate claims, and key assumptions were made explicit in internal documentation. This methodology supports rigor while remaining adaptable to new evidence and regulatory updates.

A synthesis emphasizing that validated sensing, interoperability, supply chain resilience, and aligned commercial models form the foundation for sustainable adoption and clinical impact

In conclusion, asthma monitoring devices are at an inflection point where technological capability, clinical demand for remote management, and evolving procurement dynamics converge to create new opportunities and obligations for manufacturers, providers, and payers. Devices that combine validated sensing, seamless connectivity, and demonstrable clinical utility will earn preference among institutional buyers, while consumer-focused solutions must balance ease of use with clinical data fidelity.

Operational resilience and regulatory readiness are now central to commercial viability; organizations that proactively address supply chain vulnerability, data governance, and interoperability will face fewer barriers to adoption. Moreover, cross-sector partnerships that blend clinical expertise, pharmacy reach, and digital health services will likely accelerate scalable deployment across care settings. As a result, the strategic focus should be on delivering measurable clinical outcomes, enabling integration with care workflows, and creating commercial models that align incentives across stakeholders.

Taken together, these imperatives create a roadmap for industry participants seeking to translate innovation into sustained impact: validate rigorously, design for integration, secure supply continuity, and align commercial terms to support clinical adoption and patient benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Asthma Monitoring Devices Market, by Product Type

  • 8.1. Electronic Asthma Monitor
  • 8.2. Peak Flow Meter
  • 8.3. Pulse Oximeter
  • 8.4. Smart Inhalers
  • 8.5. Spirometer
  • 8.6. Wearable Monitoring Device
    • 8.6.1. Heart Rate Sensor
    • 8.6.2. Oxygen Saturation Sensor
    • 8.6.3. Respiratory Rate Sensor

9. Asthma Monitoring Devices Market, by Technology

  • 9.1. Connected
    • 9.1.1. Bluetooth
    • 9.1.2. Cellular
    • 9.1.3. Wi-Fi
  • 9.2. Smartphone Integrated

10. Asthma Monitoring Devices Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Hospital Pharmacy
  • 10.3. Online Pharmacy
  • 10.4. Retail Pharmacy
    • 10.4.1. Brick And Mortar
    • 10.4.2. Online Marketplace

11. Asthma Monitoring Devices Market, by Power Source

  • 11.1. Battery-Operated
  • 11.2. Plug-In Electric
  • 11.3. Rechargeable

12. Asthma Monitoring Devices Market, by Application

  • 12.1. Asthma Diagnosis Support
  • 12.2. Daily Symptom Tracking
  • 12.3. Medication Adherence Monitoring
  • 12.4. Pulmonary Function Monitoring
  • 12.5. Remote Patient Monitoring (RPM)

13. Asthma Monitoring Devices Market, by Age Group

  • 13.1. Adults
  • 13.2. Geriatric
  • 13.3. Pediatrics

14. Asthma Monitoring Devices Market, by End User

  • 14.1. Ambulatory Surgical Centers (ASCs)
  • 14.2. Diagnostic Laboratories
  • 14.3. Homecare Settings
  • 14.4. Hospitals & Clinics
  • 14.5. Research & Academic Institutes

15. Asthma Monitoring Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Asthma Monitoring Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Asthma Monitoring Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Asthma Monitoring Devices Market

19. China Asthma Monitoring Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. 3M Company
  • 20.6. Adherium Limited
  • 20.7. Amiko Digital Health Limited
  • 20.8. AptarGroup, Inc.
  • 20.9. AstraZeneca plc
  • 20.10. FindAir
  • 20.11. Health Care Originals, Inc.
  • 20.12. Koninklijke Philips N.V.
  • 20.13. Masimo Corporation
  • 20.14. MGC Diagnostics Corporation
  • 20.15. Microlife Corporation
  • 20.16. Nihon Kohden Corporation
  • 20.17. Novartis AG
  • 20.18. Omron Healthcare, Inc.
  • 20.19. Sensirion AG
  • 20.20. Strados Labs, Inc.
  • 20.21. Teva Pharmaceutical Industries Ltd.
  • 20.22. Vitalograph Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ASTHMA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ASTHMA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ELECTRONIC ASTHMA MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEAK FLOW METER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULSE OXIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SPIROMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HEART RATE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY OXYGEN SATURATION SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESPIRATORY RATE SENSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY SMARTPHONE INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BRICK AND MORTAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY BATTERY-OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PLUG-IN ELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RECHARGEABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ASTHMA DIAGNOSIS SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DAILY SYMPTOM TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY MEDICATION ADHERENCE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PULMONARY FUNCTION MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING (RPM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. GCC ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 261. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 262. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. G7 ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 272. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. NATO ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE MONITORING DEVICE, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTED, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY RETAIL PHARMACY, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)